跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BE-373
首页
药物
BE-373
BE-373
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SIRT1 POLYMORPHIC VARIANTS AND METHODS OF USE THEREOF
申请人: WESTPHAL CHRISTOPH H
优先权: 2009
US
Regulatory/unfolding peptides of ezrin
申请人: HOLMS RUPERT DONALD
优先权: 1999
US
Method of diagnosing and treating acute rejection in kidney transplant patients
申请人: UNIV INDUSTRY COOPERATION GROUP KYUNG HEE UNIV
优先权: 2018
US
Structure and usage of plasminogen activator (TPA) mutant
申请人: AIR FORCE GENERAL HOSPITAL PLA
优先权: 2002
CN
ANTI-AGING COMPOSITION, ANTI-INFLAMMATORY COMPOSITION, AND METHOD FOR SCREENING AGING AMELIORATION SUBSTANCES
申请人: ROHTO PHARMA
优先权: 2024
WO
Rare earth terbium-based molecular crystalline green light material and preparation method thereof
申请人: INST APPLIED CHEMISTRY JIANGXI ACADEMY SCIENCES
优先权: 2022
CN
Preparation method of immune-strengthening carrier protein by coupling SNCG, LP-PLA2 and 11-dehydrogenation thromboxane
申请人: SHENZHEN ADIBIO TECH CO LTD
优先权: 2018
CN
ALPHA-AMYLASE VARIANTS WITH IMPROVED ACTIVITY
申请人: DANSTAR FERMENT AG
优先权: 2024
WO
药物
反馈